"Immunotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
Descriptor ID |
D007167
|
MeSH Number(s) |
E02.095.465.425
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunotherapy".
Below are MeSH descriptors whose meaning is more specific than "Immunotherapy".
This graph shows the total number of publications written about "Immunotherapy" by people in this website by year, and whether "Immunotherapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 2 | 3 |
1995 | 2 | 2 | 4 |
1996 | 4 | 3 | 7 |
1997 | 3 | 6 | 9 |
1998 | 5 | 3 | 8 |
1999 | 2 | 5 | 7 |
2000 | 2 | 7 | 9 |
2001 | 3 | 10 | 13 |
2002 | 10 | 6 | 16 |
2003 | 12 | 11 | 23 |
2004 | 8 | 11 | 19 |
2005 | 15 | 7 | 22 |
2006 | 11 | 14 | 25 |
2007 | 12 | 11 | 23 |
2008 | 12 | 22 | 34 |
2009 | 19 | 18 | 37 |
2010 | 20 | 18 | 38 |
2011 | 21 | 24 | 45 |
2012 | 18 | 20 | 38 |
2013 | 20 | 18 | 38 |
2014 | 37 | 21 | 58 |
2015 | 31 | 22 | 53 |
2016 | 45 | 41 | 86 |
2017 | 76 | 45 | 121 |
2018 | 87 | 47 | 134 |
2019 | 67 | 56 | 123 |
2020 | 109 | 71 | 180 |
2021 | 69 | 97 | 166 |
2022 | 14 | 131 | 145 |
2023 | 7 | 99 | 106 |
2024 | 1 | 20 | 21 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunotherapy" by people in Profiles.
-
The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024 Apr 08; 42(4):513-534.
-
An 18F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy. J Nucl Med. 2024 Apr 01; 65(4):520-526.
-
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC. J Exp Clin Cancer Res. 2024 Mar 15; 43(1):81.
-
Local and Systemic Management Options for Melanoma Brain Metastases. Cancer J. 2024 Mar-Apr 01; 30(2):102-107.
-
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equal. Eur J Cancer. 2024 Apr; 201:113972.
-
Tumor-resident microbes: the new kids on the microenvironment block. Trends Cancer. 2024 Apr; 10(4):347-355.
-
Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer. Cancer Res Commun. 2024 02 22; 4(2):496-504.
-
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade. Cancer Cell. 2024 Mar 11; 42(3):429-443.e4.
-
Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy. Proc Natl Acad Sci U S A. 2024 Feb 20; 121(8):e2306973121.
-
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma. Radiother Oncol. 2024 Apr; 193:110121.